[HTML][HTML] Involvement of the endosomal autoantigen EEA1 in homotypic fusion of early endosomes

IG Mills, AT Jones, MJ Clague - Current Biology, 1998 - cell.com
Current Biology, 1998cell.com
In mammalian cells, fusion between early endocytic vesicles has been shown to require the
ubiquitous intracellular fusion factors N-ethylmaleimide-sensitive factor (NSF) and α-SNAP,
as well as a factor specific for early endosomes, the small GTPase Rab5 [1–3]. We have
previously demonstrated an additional requirement for phosphatidylinositol 3-kinase (PI 3-
kinase) activity [4]. The membrane association of early endosomal antigen 1 (EEA1), a
specific marker of early endosomes [5, 6], has recently been shown to be similarly …
Abstract
In mammalian cells, fusion between early endocytic vesicles has been shown to require the ubiquitous intracellular fusion factors N-ethylmaleimide-sensitive factor (NSF) and α-SNAP, as well as a factor specific for early endosomes, the small GTPase Rab5 [1–3]. We have previously demonstrated an additional requirement for phosphatidylinositol 3-kinase (PI 3-kinase) activity [4]. The membrane association of early endosomal antigen 1 (EEA1), a specific marker of early endosomes [5,6], has recently been shown to be similarly dependent on PI 3-kinase activity [7], and we therefore postulated that it might be involved in endosome fusion. Here, we present evidence that EEA1 has an important role in determining the efficiency of endosome fusion in vitro. Both the carboxy-terminal domain of EEA1 (residues 1098–1411) and specific antibodies against EEA1 inhibited endosome fusion when included in an in vitro assay. Furthermore, depletion of EEA1, both from the membrane fraction used in the assay by washing with salt and from the cytosol using an EEA1-specific antibody, resulted in inhibition of endosome fusion. The involvement of EEA1 in endosome fusion accounts for the sensitivity of the endosome fusion assay to inhibitors of PI 3-kinase.
cell.com